版本:
中国

BRIEF-Proteostasis provides update on PTI-428 amplifier clinical data

June 7 Proteostasis Therapeutics Inc

* PTI-428 amplifier clinical data in three separate populations of CF patients on track for mid-year

* PTI-801 new generation corrector phase 1 healthy volunteer sad study complete; mad study underway

* PTI-808 potentiator advancing to IND; DRF study intended to be POC for triple combination by year end 2017 Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1 646 223 8780)

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐